Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Clover Completes BLA Submission for Seasonal Influenza Vaccine in Brazil 2023-11-07 08:00
Epidemiology and Genetics of Clonal Hematopoiesis, a Premalignant Hematopoietic Stem Cell Condition 2023-11-07 00:00
Phase I Study Results for Qilu Pharmaceutical's Iparomlimab (QL1604) Now Published 2023-11-06 18:54
Novogene AMEA adopts Olink® Explore HT platform 2023-11-06 18:00
'Listen to your patients for early identification of Peripheral Neuropathy' say leading Health Experts at P&G's #KNOWTHESIGNS Scientific Forum 2023-11-06 17:07
Meet Joey Rabbit, the New AI-Powered 3D Virtual Mental Health Butler from Bamboo Technology 2023-11-06 16:21
The Farrer Park Company Pte Ltd Appoints Ms Kelly Yang as Chief Executive Officer of Farrer Park Hospital 2023-11-06 12:27
Gannex Published Phase I Data of ASC42, a Novel Farnesoid X Receptor Agonist on the Journal Drugs in R&D 2023-11-06 12:20
XtalPi and CK Life Sciences Ink Agreement to Develop Cancer Molecular Diagnostic Models using AI and Biomarker Data 2023-11-06 09:00
Innovent Presents Clinical Data of Two Ophthalmic Bispecific Antibodies IBI302 (anti-VEGF/complement) and IBI324 (anti-VEGF-A/Ang-2) at American Academy of Ophthalmology (AAO) Annual Meeting 2023 2023-11-06 08:00
Pierre Fabre Laboratories to accelerate their development in onco-hematology by acquiring the license for a breakthrough T-cell immunotherapy in North America 2023-11-04 00:52
Verismo Therapeutics Announces Upcoming Presentation at SITC 2023 2023-11-03 21:00
Mediwave Unveils AI-Powered Emergency Response Suite and Smart Ambulance with Mixed Reality Tech in Malaysia 2023-11-03 13:59
Frost & Sullivan Honors Komodo Health with Technology Innovation Leadership Award for Its Data-Driven Platform to Improve Patient Care 2023-11-02 23:48
Lion TCR clinched the prestigious T-Up Excellence Awards in Singapore 2023-11-02 20:41
European Medicines Agency validates Pierre Fabre Laboratories' marketing authorisation application for combination BRAFTOVI® (encorafenib) and MEKTOVI® (binimetinib) for patients with BRAFV600-mutant advanced non-small cell lung cancer (NSCLC) 2023-11-02 18:52
Cambrex Announces Sale of Drug Product Business Unit 2023-11-02 18:00
Xinhua Silk Road: 54th Zhangshu National Traditional Chinese Materia Medica Trade Fair kicks off in E. China's Jiangxi 2023-11-02 14:21
Myrkl - The NEW Liver Function and Detox Support Supplement that sold out in 24hrs 2023-11-02 11:25
Chula Launches the Latest Parkinson's Gloves to Reduce Tremors 2023-11-02 10:00
1 73 74 75 76 77 531